Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by cjdavid1on Jun 26, 2010 11:50am
374 Views
Post# 17224514

Odd behaviour from the "I told u so" clan

Odd behaviour from the "I told u so" clanI echo KayDay's post. Her/His contributions have been Excellent. After re-reading the posts (and wearing down my iggy key to a nub), the last-minute newbies to the Board - those naysaying nogoodniks - LIE just to get your shares cheap. The length of some of their posts  shows interest on their part. USE your  " Ignore User " function under the icon, click on the down arrow.

I must highlight certain points KayDay stated to show why they want you to sell your shares cheap to them (ew).  As KayDay put it: "We know that our drug is non toxic. We know that there are no other drugs in this space and a desperate need for one. We know that the sample size was small and have found countless articles that state that small sample sizes are more likely to experience the placebo effect, and Big Pharmas know this. We know that our drug works... secondary endpoints were positive."

If mgmt initiated another Phase IIb trial, I bet we won't get such a placebo effect.

Carpe Diem !

CJ
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse